Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)
Clinical trial NCT05431244 · WITHDRAWN
Trial details
- NCT number
- NCT05431244
- Sponsor
- Samsung Medical Center
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.